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Abstract
!
Tetrahydrofuran lignans represent a well-known group of phe-
nolic compounds capable of acting as antiparasitic agents. In the
search for new medicines for the treatment of Chagas disease,
one promising compound is grandisin which has shown signifi-
cant activity on trypomastigote forms of Trypanosoma cruzi. In
this work, the in vitro metabolism of grandisin was studied in
the pig cecummodel and by biomimetic phase I reactions, aiming
at an ensuing a preclinical pharmacokinetic investigation.
Although grandisin exhibited no metabolization by the pig mi-
crobiota, one putative metabolite was formed in a biomimetic
model using Jacobsen catalyst. The putative metabolite was
tested against T. cruzi revealing loss of activity in comparison to
grandisin.
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There are few studies on intestinal and phase I metabolites of
natural products [1–3]. During the last years the “pig cecum
model” was developed and further improved, showing good re-
sults for the metabolization of phenolic compounds [4–10]. For
phase I metabolism, several in vitro biomimetic models were de-
veloped, while Mn(salen) appeared as an alternative to produce
similar metabolites of CYP450 enzymes [11,12] yielding a puta-
tive metabolite in a good scale [13,14]. Previous investigations
of the trypanocidal activity of tetrahydrofuran lignans showed
several significant results [15–17] which were already registered
as a patent [18]. Chagas disease affects more than 10million peo-
ple in theworld and is concentrated in Latin Americawhere it has
an impact on the medical health system [19]. In this context, the
aim of this work was to investigate the metabolism of grandisin
in the pig cecum model by applying biomimetic reactions in or-
der to improve information on its preclinical pharmacokinetic
and also on the biological activity of the putative metabolite.
Under the chosen experimental conditions, no metabolization of
grandisin was observed in the pig cecum model. Even though
there are some studies showing fungal grandisin metabolism
[20] and metabolism of lignans from flax by intestinal bacteria
[21], the yield was very low and apparently the bacteria from
the pig intestinal tract were not able to metabolize this lignan.
The high recovery value observed in addition to the control me-
tabolization using quercetin eliminates any possibility of techni-
cal problems. This result indicates high intestinal stability of
grandisin, which is one prerequisite for good absorption in an
oral administration.
Recently, the biotransformation of grandisin by rat liver micro-
somes showed a dehydro metabolite [22] suggesting that a possi-
ble oxidized metabolite may be formed by liver phase I reactions.
To confirm this proposition, we applied a biomimetic oxidation of
grandisin catalyzed by Mn(salen). The results demonstrate the
presence of two products, a minor signal resulting from the oxi-
dative cleavage of grandisin, as previously observed for caterpil-
larsʼ metabolism [23]. A second product was isolated by TLC and
characterized as dehydro-grandisin: 3,4-dimethyl-2,5-bis(3,4,5-
trimethoxyphenyl)-2,3-dihydrofuran (2) (l" Fig. 1).
The ESI-HRMS spectrum showed the [M + H]+ signal at m/z
431.2064, confirming the molecular formula as the same as ob-
served for the product obtained after metabolization by liver mi-
crosomes [22]. The putative metabolite was submitted to 1H NMR
analysis, and the data was compared to grandisin. Grandisin has
trans,trans,trans relative stereochemistry, so that the oxyben-
zylic and methynic protons are equivalent. In contrast, the puta-
tive metabolite lost this symmetry and appeared as two sets of
signals with similar chemical shifts at δH 6.67 and δH 6.58 ppm
for the aromatic protons H-2/H-6 and H-2′/H‑6′, respectively.
The same effect was observed for the –OCH3 singlets confirming
the symmetry loss and that no reaction occurred in any aromatic
ring. The major difference was observed for the positions H-7/H-
7′ and H-8/H-8′. The integration of the well-defined signals at δH
4.80 (H-7′, d, J = 8.6 Hz) and at δH 2.91 (H-8′, m) allowed to deter-
mine the occurrence of one proton per peak and also a deshield-
ing effect in relation to the signals from grandisin [23]. The same
deshielded effect was observed for the methyl protons at C-9
(1.84 d, J = 1.4 Hz). Finally, to confirm the stereochemistry of de-
Fig. 1 Structures of
grandisin (1) and its de-
hydro putative metabo-
lite (2).
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hydro-grandisin, the CD spectra were recorded for the metabo-
lite and grandisin. Both spectra showed two similar bands, one
centered at about 208 (positive) and other at 243 nm (negative)
for grandisin and themetabolite, proving that they have the same
configuration (R,R) [24].
The final stepwas to define if the putative metabolite still had bi-
ological activity as observed with grandisin against the trypo-
mastigote form of T. cruzi [2]. After isolation, dehydro-grandisin
was evaluated against this parasite. The absence of activity indi-
cates that the opposite spacial geometry of rings and methyl
groups is important in the grandisin molecule to show an effect
against this parasite.
Materials and Methods
!
Piper solmsianum C. DC. was collected in Ubatuba (São Paulo, Bra-
zil) and identified by Dr. Elci Franklin Guimarães (Jardim Botâni-
co do Rio de Janeiro, Brazil) where a voucher specimen (329676)
is deposited. This work was carried out with the CGEN license
number 005/2009. Dried and pulverized leaves were extracted
as previously described, and (−)grandisin (98%, determined by
GC‑MS) was obtained [25].
(−)Grandisin was assayed in the pig cecum model and the Mn
(salen) oxidation procedure as reported before. The putative me-
tabolite obtained using Mn(salen) was assayed against T. cruzi in
a specific and sensitive test [26]. For a description of these meth-
ods, see Supporting Information.
3,4R-Dimethyl-2,5R‑bis(3,4,5-trimethoxyphenyl)-2,3-dihydrofu-
ran (2): white powder;[α]D27 = − 69.1 (0.09 g/100mL MeCN); UV
(CH3CN) λmax 239, 270 nm; CD (CH3CN) θ 207 + 4.8, θ 217 + 5.2,
θ 241–4.4, θ 296 − 1.1, θ 318 − 1.2mdeg (4.4 10−4mol/L); 1H
NMR (CDCl3, 300MHz) δH 6.67 (s, H-2,6), 6.58 (s, H-2′,6′), 4.80
(d, J = 8.6, H-7′), 3.82 (s, OCH3 at 4), 3.81(s, OCH3 at 3,5), 3.80 (s,
OCH3 at 4′,3′,5′), 2,91 (m, H-8′), 1.84 (d, J = 1.4, H-9), 1.03 (d,
J = 6.5, H-9′); ESI MS (pos. ion mode) m/z 431.2062 [M + H]+
(calcd. for C24H30O7 431.2064); EI MS m/z (% rel int): 430 ([M]+,
45), 348 (21), 347 (100), 247 (21), 235 (17), 219 (16), 204 (19),
195 (61).
Supporting information
The detailed information about grandisin assays, data for the pig
cecum model, and dehydro-grandisin characterization spectra
are available as Supporting Information.
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